Buzzai et al. [18] also reported that metformin selectively impaired cell growth in p53 null colorectal cancer cells by inhibiting autophagy but activated autophagy in p53 wild-type colorectal cancer cells. The gene discussed is TP53; the disease is colorectal cancer.